Scan to downloadFuso Pharmaceutical Industries,Ltd. (4538) Earnings Releases & Disclosures
| Date | Type | Title | Files |
|---|---|---|---|
| 2026-11-11 | Earnings Release | [Summary] Non-consolidated Financial Results for the Six Months Ended September 30, 2026 [Under Japanese GAAP] | |
| 2026-11-11 | Forecast Revision | Notice Concerning Revisions to Financial Result Forecasts and Dividend Forecasts for the Fiscal Year Ending March 31, 2027 | |
| 2026-11-11 | — | Notice Concerning Appointment of Executive Officers and Organizational Changes | |
| 2026-11-11 | Earnings Release | Supplementary Material on Financial Results for the Six Months Ended September 30,2026 | |
| 2026-11-04 | Forecast Revision | Notice Concerning Revisions to Financial Result Forecasts for the Six Months Ended September 30, 2026 | |
| 2026-09-30 | — | Notice Concerning Conclusion of Design-Build Contract for Okayama Second Factory | |
| 2026-08-18 | Earnings Release | [Updated]Non-consolidated Financial Results for the Three Months Ended June 30, 2026[Under Japanese GAAP] | |
| 2026-08-10 | Earnings Release | [Summary]Non-consolidated Financial Results for the Three Months Ended June 30, 2026[Under Japanese GAAP] |
TDnet keeps only 31 days; this site accumulates daily and cannot backfill earlier disclosures.